Stevan Jovanovich, Ph.D.
Founder & CEO
Dr. Stevan Jovanovich is the President/CEO of both S2 Genomics, Inc., and its parent Silicon Valley Scientific, Inc. S2 Genomics was founded in 2016 to develop integrated sample preparation systems for genomics focusing on tissue samples. Previously, he was President/CEO/Founder and CTO of IntegenX, Inc., a Silicon Valley Scientific, Inc. spinout. IntegenX is the global leader in rapid human identification. Dr. Jovanovich is a co-founder and Director of Functional Biosciences, Inc., a leading CLIA DNA sequencing laboratory.
Before co-founding Silicon Valley Scientific, Inc., Dr. Jovanovich was Vice President of Global Research at Amersham Biosciences. Prior positions include Science Director at Amersham Biosciences Sunnyvale, Manager of Advanced Research at Molecular Dynamics, Staff Scientist at Lawrence Berkeley National Laboratory, Director of Microbiology at AbTox Inc, founder of Molecular Solutions, and Applications Programmer at the Institute for Defense Analyses.
He is author of 28 peer-reviewed papers and reviews, an inventor on over 70 patents, and has automated life science workflows since 1987. He holds Bachelor of Science degrees in Physics and Life Sciences from MIT, a Ph.D. in Microbiology from University of California at Davis with a minor in Molecular Biology, and a Certificate in Object-Oriented Programming from the University of California Santa Cruz Extension.
Anup Parikh, Ph.D.
Board Member
As an Operating Partner at BroadOak Capital Partners, Dr. Parikh specializes in steering the firm’s initiatives within the molecular biology segment. His strategic oversight extends to several key enterprises in the life sciences field, where he serves as a board member at S2 Genomics and seqWell, as well as a board observer at Phenovista and NanoCellect.
Anup Parikh has dedicated over 15 years to the commercialization of innovative technologies that have had a substantial impact on the Biopharma, Life Sciences, and Diagnostics industries. Before joining BroadOak Capital Partners, Anup held product strategy positions at several prominent companies, including Mission Bio, 10x Genomics, and Ion Torrent. His strategic vision and execution have been instrumental in successfully launching over 50 products, encompassing a wide range of tools such as new instrumentation, kits, and analysis software.
Anup received his Ph.D. from Baylor College of Medicine in Structural and Computational Biology.
Michael J. Finney, Ph.D.
Board Member
Dr. Finney is a board director or advisor to multiple biotechnology companies, with an emphasis on companies that supply fundamental technologies. He currently serves on the board of directors of 7 privately held companies, plus one public company, Vaxart (VXRT), where he also served as CEO for two years. He co-founded and serves on the board of The Genome Partnership, a nonprofit that runs AGBT, the leading annual conference on genomic technology. Previously, he co-founded MJ Research, a manufacturer of instruments used in genomic technology. The bootstrapped company was sold to Bio-Rad in 2004.
